Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OSBPL9P3 refers to a pseudogene named "oxysterol binding protein like 9 pseudogene 3." Pseudogenes do not typically encode functional proteins and are generally regarded as non-coding segments of DNA related to ancestral or paralogous genes. There is no evidence in current biomedical literature or molecular target resources that OSBPL9P3 is functionally expressed, acts as a therapeutic target, or participates in physiological or pathological processes. The oxysterol-binding protein family (e.g., OSBPL3, as cited in search results) includes several known functional proteins involved in lipid metabolism and signaling[1][2], but OSBPL9P3 itself is not referenced as a functional or disease-associated entity. No aliases, disease roles, biomarkers, drug interactions, or safety considerations are associated with OSBPL9P3 in curated pharmacology or genomics databases. This target is likely mis-specified, non-functional, or an erroneous entry. Supporting Explanation: - OSBPL9P3 does not appear in major genomics databases as a functional or druggable target. It is annotated as a pseudogene and not a protein-coding gene, so by definition, it does not encode a receptor, enzyme, transporter, or other pharmacologically relevant target. - The related functional family member is OSBPL3, which is a protein-coding gene involved in lipid signaling, vesicular transport, and multiple cancers[1][2], but OSBPL9P3 is not referenced as participating in any of those mechanisms. - If the query was intended for OSBPL3 or OSBPL9, information should instead be requested for those canonical entities, which are valid targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol binding protein like 9 pseudogene 3 (OSBPL9P3).